Theratechnologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Theratechnologies generated cash of -$5,678,000, which is more than the previous year. Cash used in financing activities reached the amount of $14,775,000 last year. Net change in cash is therefore $10,241,000.
Cash Flow
| 2014 | -7.04M | 6.80M | 0 |
|---|---|---|---|
| 2015 | 5.31M | 1.90M | 3.39M |
| 2016 | 2.00M | -9.36M | -3.61M |
| 2017 | 1.90M | -16.09M | 13.71M |
| 2018 | -334.06K | -10.68M | 46.84M |
| 2019 | -3.39M | -130K | -6.80M |
| 2020 | -13.55M | 4.77M | -7.22M |
| 2021 | -14.47M | -12.45M | 37.86M |
| 2022 | -14.69M | 8.68M | 9.65M |
| 2023 | -5.67M | 1.10M | 14.77M |
THTX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 23.85M | 20.39M | 12.73M | 28.66M | 38.99M | 1.36M | 788.54K | 11.51M | 608.20K | 913.02K |
Operating activities | ||||||||||
Net income | -23.95M | -47.23M | -31.72M | -22.66M | -12.49M | -4.52M | -14.30M | 305.29K | 1.17M | -9.23M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.30M | 12.47M | 8.74M | 8.52M | 7.49M | 4.14M | 1.54M | 1.56M | 1.43M | 1.00M |
Stock-based compensation expense | 1.99M | 3.87M | 1.93M | 1.42M | 1.08M | 0 | 833.26K | 419.21K | 111.04K | 109.54K |
| Deferred income tax benefit | 1.99M | 3.87M | 1.93M | 1.42M | 1.08M | 0 | 833.26K | 419.21K | 111.04K | 109.54K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -902K | -1.66M | 1.85M | -2.25M | 831K | -3.40M | -2.57M | -1.56M | -1.24M | -1.64M |
Inventories | 10.32M | 8.99M | -4.18M | -4.87M | -9.86M | -3.89M | 977.43K | 446.02K | -366.13K | -608.20K |
Accounts payable | -3.21M | 2.08M | 5.54M | 3.43M | 3.85M | 7.61M | 9.82M | -1.60M | 2.72M | 0 |
Cash generated by operating activities | -5.67M | -14.69M | -14.47M | -13.55M | -3.39M | -334.06K | 1.90M | 2.00M | 5.31M | -7.04M |
Investing activities | ||||||||||
Purchases Of Investments | -104K | -239K | -12.75M | -99K | -213K | -16.94M | -41.16M | -37.70M | 0 | 0 |
Investments In Property Plant And Equipment | -318K | -985K | -166K | -32K | -3.62M | -19.28M | -32.55K | -23.08K | 0 | -876 |
Acquisitions Net | 0 | -9.66M | 12.39M | -4.40M | -2.29M | 0 | 0 | 0 | 51.06K | 0 |
Cash generated by investing activities | 1.10M | 8.68M | -12.45M | 4.77M | -130K | -10.68M | -16.09M | -9.36M | 1.90M | 6.80M |
Financing activities | ||||||||||
Common Stock Issued | 25.16M | 2.96M | 43.09M | 150.43K | 110.06K | 616.95K | 12.82M | 253.60K | 7.55M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -7.90M | 10.64M | -635K | -568K | -3.5M | -46.22M | -4.17M | -3.86M | 0 | 0 |
Cash used in financing activities | 14.77M | 9.65M | 37.86M | -7.22M | -6.80M | 46.84M | 13.71M | -3.61M | 3.39M | 0 |
Net Change In Cash | 10.24M | 3.45M | 7.66M | -15.92M | -10.33M | 37.63M | 575.68K | -10.72M | 10.90M | -304.82K |
Cash at end of period | 34.09M | 23.85M | 20.39M | 12.73M | 28.66M | 39.00M | 1.36M | 788.54K | 11.51M | 608.20K |
| Data source | Data source | Data source |